Shallow WGS of individual CTCs identifies actionable targets for
Untargeted profiling of cell-free circulating DNA - Zhou - Translational Cancer Research
Liquid biopsy enters the clinic — implementation issues and future challenges
Cancers, Free Full-Text
Heat map representation of CTC-shared CNVs in newly diagnosed
ctDNA mutation spectrum. a Mutation spectrum of each case. Number
The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer - ScienceDirect
Frontiers Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
Prediction of breast cancer risk based on flow-variant analysis of
Prediction of breast cancer risk based on flow-variant analysis of
Potential clinical utility of liquid biopsies in ovarian cancer. - Abstract - Europe PMC
Survival analyses. Kaplan-Meier estimates for patients without
Utility of ctDNA to support patient selection for early phase
PDF) Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival